Biomemory has launched DNA Shield, an offline, air-gapped repository service designed to store critical digital assets within synthetic DNA. The company aims to protect cold data—information that must remain unaltered, such as cryptographic keys, financial records, passwords, biometrics, and intellectual property—from modern cyber threats and advanced artificial intelligence technologies.
The system encodes information into physical molecules that require no power for long-term preservation. This synthetic DNA storage medium offers a lifespan of up to 150 years and boasts a density significantly higher than traditional magnetic storage. The commercial rollout follows Biomemory's acquisition of Boston-based DNA storage pioneer Catalog Technologies in March 2026, marking the transition of the technology from a research demonstration into a marketable product.
Pilot slots for DNA Shield are currently open through mid-2027, with a full service rollout planned afterward. Interested organizations can apply for early access directly through Biomemory, with subscriptions starting at 10,000 euros per month. Company leadership notes that this initiative represents the debut of molecular IT, providing enterprises with a secure method to safeguard vital institutional records entirely out of reach from cloud environments and cybercriminals.
Biomemory Launches DNA Shield to Store Critical Data in Synthetic DNA
Comments